These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1450875)

  • 41. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Psychosocial aspects of the climacteric].
    Buddeberg C; Buddeberg-Fischer B
    Praxis (Bern 1994); 1995 Jun; 84(24):718-21. PubMed ID: 7792468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study on the use of medication for climacteric complaints in western Europe--II.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1994 May; 19(1):1-12. PubMed ID: 7935027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.
    Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I
    Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.
    Nappi RE; Davis SR
    Climacteric; 2012 Jun; 15(3):267-74. PubMed ID: 22612614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen and alternative therapy of the menopausal patient.
    Lichten EM
    Prim Care; 1978 Dec; 5(4):607-14. PubMed ID: 253359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevalence of sexual dysfunction in climacteric women. Influence of menopause and hormone replace therapy].
    Blümel JE; Araya H; Riquelme R; Castro G; Sánchez F; Gramegna G
    Rev Med Chil; 2002 Oct; 130(10):1131-8. PubMed ID: 12491830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen replacement therapy and menopause.
    Odom MJ; Carr BR
    Compr Ther; 1987 Dec; 13(12):58-63. PubMed ID: 3440374
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of the menopause.
    Marsh MS; Whitehead MI
    Br Med Bull; 1992 Apr; 48(2):426-57. PubMed ID: 1450878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Menopause and estrogen replacement therapy.
    Stuenkel CA
    Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen replacement therapy.
    Sarrel PM
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):2S-5S. PubMed ID: 3173938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 58. Skin climacteric aging and hormone replacement therapy.
    Quatresooz P; Piérard-Franchimont C; Gaspard U; Piérard GE
    J Cosmet Dermatol; 2006 Mar; 5(1):3-8. PubMed ID: 17173565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Indications and controindications of hormone replacement therapy in menopause].
    Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM
    Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.